Acuta Capital Partners’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YF
SL
Acuta Capital Partners's WHWK Position: Q3 2026 in Review
Acuta Capital Partners held its Whitehawk Therapeutics (WHWK) position steady in Q3 2026 at 4,685,912 shares worth $17.6M. The position accounts for 13.39% of the portfolio, ranked #2.
Acuta Capital Partners first reported a position in WHWK in Q3 2021 and has held it in 21 quarters since. The position peaked at $44.9M in Q3 2021. 89 funds tracked by Wall St. Rank hold WHWK as of Q3 2026.
- Acuta Capital Partners held 4,685,912 shares of Whitehawk Therapeutics worth $17.6M as of Q3 2026.
- Acuta Capital Partners left its Whitehawk Therapeutics share count unchanged in Q3 2026.
- Whitehawk Therapeutics made up 13.39% of Acuta Capital Partners's portfolio in Q3 2026, its #2 holding.
- Acuta Capital Partners first reported a position in Whitehawk Therapeutics in Q3 2021 and has held it in 21 quarters since.
- Acuta Capital Partners's Whitehawk Therapeutics position peaked at $44.9M in Q3 2021.
- 89 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2026.
Based on Acuta Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.